Trial Information - Phase N/A
Prospective multicenter observational study of patients with relapsed or refractory diffuse large B-cell lymphoma starting second- or third-line therapy and not receiving autologous stem cell transplant
Disease Specifics: (DLBCL)
Protocol ID: MOR208C414
Sponsor: Morphosys
Status: PENDING OPEN
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724
